Verition Fund Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,400
Closed -$79.3K 3345
2024
Q1
$79.3K Sell
19,400
-1,400
-7% -$6.26K ﹤0.01% 2604
2023
Q4
$122K Buy
+20,800
New +$109K ﹤0.01% 2126

Other funds holding AUGX

Verition Fund Management's AUGX Position: Q2 2024 in Review

Verition Fund Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 19,400 shares — an estimated $79.3K sold.

Verition Fund Management first reported a position in AUGX in Q4 2023 and held it in 2 quarters. The position peaked at $122K in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Verition Fund Management reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Verition Fund Management sold 19,400 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $79.3K.
  • Verition Fund Management first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Verition Fund Management's Augmedix, Inc. Common Stock position peaked at $122K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.